APYX

Apyx Medical Corporation Common Stock

3.89

USD

APYX Earnings Reports

Positive Surprise Ratio

APYX beat 27 of 40 last estimates.

68%

Next Report

Date of Next Report

Mar 11, 2026

Estimate for Q4 25 (Revenue/ EPS)

$18.24M

-$0.06

Implied change from Q3 25 (Revenue/ EPS)

+41.63%

+20.00%

Implied change from Q4 24 (Revenue/ EPS)

+28.23%

-50.00%

Apyx Medical Corporation Common Stock earnings per share and revenue

On Nov 06, 2025, APYX reported earnings of -0.05 USD per share (EPS) for Q3 25, beating the estimate of -0.10 USD, resulting in a 52.20% surprise. Revenue reached 12.88 million, compared to an expected 12.24 million, with a 5.18% difference. The market reacted with a +6.69% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 7 analysts forecast an EPS of -0.06 USD, with revenue projected to reach 18.24 million USD, implying an increase of 20.00% EPS, and increase of 41.63% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Phibro Animal Health Corporation Class A

Report Date

Feb 04, 2026 For Q2 26

Estimate

$0.68

Actual

$0.87

Surprise

+27.30%

Canopy Growth Corporation Common Shares

Report Date

Feb 06, 2026 For Q3 26

Estimate

-$0.04

Actual

-$0.13

Surprise

-198.00%

Aurora Cannabis Inc. Common Shares

Report Date

Feb 04, 2026 For Q3 26

Estimate

$0.21

Actual

$0.12

Surprise

-42.72%

High Tide Inc. Common Shares

Report Date

Jan 29, 2026 For Q4 25

Estimate

$0.00

Actual

-$0.56

Surprise

0.00%

Stryker Corporation

Report Date

Jan 29, 2026 For Q4 25

Estimate

$4.43

Actual

$4.47

Surprise

+0.69%

Boston Scientific Corp.

Report Date

Feb 04, 2026 For Q4 25

Estimate

$0.78

Actual

$0.80

Surprise

+1.61%

ResMed Inc.

Report Date

Jan 29, 2026 For Q2 26

Estimate

$2.75

Actual

$2.81

Surprise

+2.15%

GE HealthCare Technologies Inc. Common Stock

Report Date

Feb 04, 2026 For Q4 25

Estimate

$1.42

Actual

$1.44

Surprise

+0.96%

Envista Holdings Corporation Common stock, $0.01 par value per share

Report Date

Feb 05, 2026 For Q4 25

Estimate

$0.32

Actual

$0.38

Surprise

+15.43%

Prestige Consumer Healthcare Inc.

Report Date

Feb 05, 2026 For Q3 26

Estimate

$1.15

Actual

$1.13

Surprise

-1.36%

FAQ

What were Apyx Medical Corporation Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Apyx Medical Corporation Common Stock reported EPS of -$0.05, beating estimates by 52.2%, and revenue of $12.88M, 5.18% above expectations.

How did the market react to Apyx Medical Corporation Common Stock's Q3 2025 earnings?

The stock price moved up 6.69%, changed from $3.14 before the earnings release to $3.35 the day after.

When is Apyx Medical Corporation Common Stock expected to report next?

The next earning report is scheduled for Mar 11, 2026.

What are the forecasts for Apyx Medical Corporation Common Stock's next earnings report?

Based on 7 analysts, Apyx Medical Corporation Common Stock is expected to report EPS of -$0.06 and revenue of $18.24M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.